News
Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD)’s stock, assigning a “Buy” rating with the price ...
Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...
Growing up in the Sanders household means cameras are always rolling and competition never takes a day off. From Coach Prime's press conferences to Shilo's monthly sibling rankings ...
Insulet has shown impressive revenue and profit growth, driven by its Omnipod System and expanding global presence. Read more ...
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand ...
Endocrinologist with NL Health Services, Dr. Zaina Albalawi, says continuous blood sugar monitoring is the standard of care ...
The global insulin pumps market, valued at USD 5.5 billion in 2022, is poised for remarkable growth, with an anticipated compound annual growth rate (CAGR) of 10.3% from 2022 to 2032, according to a ...
Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1 MANCHESTER, N.H., ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Global Insulin Pumps Market ...
Each week in England alone, diabetes is responsible for an estimated 812 strokes, 568 heart attacks, and 2,909 cases of heart ...
Danish couple August and Marie Krogh founded Nordsik Insulinlaboratorium in 1923 and commercialized the production of insulin. The company competed with Novo Terapeutisk Laboratorium, which was ...
In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results